Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-inferiority of Cysticlean versus fosfomycin for treatment of cystitis in women
2015-005706-11Phase 4Terminated
- Sponsor
- Vita Green Europa S.A.
- Start
- Jan 2016
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in urinary tract infection (UTI) comparing Cysticlean arm with Fosfomycin arm (2 arms). Primary endpoint: Treatment failure rate. Started Jan 2016; status: terminated.
02
Drugs
Cysticleanfosfomycin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2015-005706-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005706-11.